Onasemnogene Abeparvovec Intravenous (Zolgensma®) Service & Onasemnogene Abeparvovec Intrathecal (OAV101 IT) Service
NHS EnglandEstimated Value
Up to £26,136,000
Deadline
8 July 2026
27 days remaining
Published
4 June 2026
Type
services
Overview
Onasemnogene abeparvovec intravenous (Zolgensma®) is a one-time, in vivo gene replacement therapy, for use in babies aged 12 months and under, that utilises an adeno-associated virus serotype 9 (AAV9) vector, modified to contain a functional copy of the human SMN1 gene. It is administered intravenously, allowing the vector to deliver the gene into motor neurones and peripheral tissues, enabling the sustained expression of survival motor neuron (SMN) protein, which is deficient or mutated in individuals with SMA.
Onasemnogene abeparvovec intrathecal (OAV101 IT) is a one-time in vivo gene replacement therapy for patients with SMA, proposed to treat individuals with SMA aged 2 years and over. This intrathecal injection will be used to treat a distinct cohort of SMA patients to Zolgensma. It will be assessed via NICE’s technology appraisal programme, with an expected final guidance publication date in late 2026.
Lots (3)
- Lot 1Zolgensma only (if no positive NICE recommendation for OAV101 IT)
- Lot 2Positive recommendation for OAV101 IT for paediatric patients (in combination with Lot 1 for Zolgensma)
- Lot 3Positive NICE recommendation for OAV101 IT for adult patients (either standalone or in combination with Lots 1 and 2)
AI Analysis
Powered by AI — always verify against official documents
The NHS is seeking to commission two gene therapy services for treating Spinal Muscular Atrophy (SMA): Zolgensma® for babies under 12 months (intravenous injection) and OAV101 IT for older children and adults aged 2+ (intrathecal injection into the spine). This is a highly specialised medical service requiring expertise in administering one-time genetic treatments that replace a faulty gene with a working copy.
Requirements
- Ability to deliver intravenous gene therapy (Zolgensma®) to infants aged 12 months and under
- Ability to deliver intrathecal gene therapy (OAV101 IT) to patients aged 2 years and over
- Expertise in managing adeno-associated virus (AAV9) vector-based gene therapies
- Capacity to monitor sustained expression of survival motor neuron (SMN) protein post-treatment
- Compliance with NICE technology appraisal guidance (expected late 2026 for OAV101 IT)
- Specialist staff trained in administering one-time in vivo gene replacement therapies
- Infrastructure to store, handle, and administer AAV9-based treatments safely
- Experience managing SMA patient cohorts and monitoring long-term outcomes
Key Tasks & Deliverables
- Administer Zolgensma® intravenously to babies aged 12 months and under with SMA
- Deliver intrathecal OAV101 injections to SMA patients aged 2 years and older
- Monitor patients post-treatment for sustained SMN protein expression and clinical outcomes
- Manage distinct patient cohorts (infants receiving Zolgensma versus older children/adults receiving OAV101 IT)
- Implement NICE-approved treatment pathways once guidance is published (late 2026 for OAV101 IT)
- Provide ongoing specialist clinical support and follow-up care after gene therapy administration
How to Read This Tender
- 1This tender has three separate 'Lots' (contract options) — Lot 1 is Zolgensma only, Lot 2 adds OAV101 IT for children, and Lot 3 adds OAV101 IT for adults. You may be asked to bid for one, two, or all three depending on your capacity. Check which Lot(s) apply to you.
- 2The approval status of OAV101 IT is conditional on NICE's final guidance (expected late 2026) — Lot 1 stands alone regardless, but Lots 2 and 3 depend on a positive NICE recommendation. Understand that timescales may shift based on NICE's decision.
- 3This is 'gene therapy' — a highly specialist field. The tender expects you to understand AAV9 vectors, intrathecal and intravenous administration routes, and long-term patient monitoring. If this is new territory, partner with a specialist provider or subcontractor.
- 4Look carefully at the full tender documents for: patient eligibility criteria, staffing and training requirements, storage/handling conditions for the therapy, and performance metrics for monitoring outcomes post-treatment.
- 5SMA (Spinal Muscular Atrophy) is rare, so patient numbers will be small. Focus on quality, safety, and specialist expertise rather than scale. Highlight any existing experience with rare genetic conditions or specialist therapies.
Tips for Small Businesses
- If you're not a large NHS trust, consider forming a consortium with a specialist gene therapy centre or hospital with existing infrastructure for rare disease management. Many SMEs win by subcontracting specialist delivery to experienced partners while providing other support services (e.g., patient coordination, monitoring, allied health support).
- Emphasise any track record with rare paediatric conditions, genetic disorders, or specialist intravenous/intrathecal therapies. Even if you haven't delivered gene therapy before, highlight relevant experience with complex infant care or spinal injections — this demonstrates capability in high-risk clinical environments.
- Social value scoring may favour providers who commit to patient support services (e.g., genetic counselling, family support networks, transition pathways from paediatric to adult care). Building these into your bid can differentiate you, especially as this affects small patient cohorts who benefit from holistic care.
Independent software, web & cloud studio. We design, build and grow digital products that quietly outlast their category.
How to Apply
Step-by-step submission guide
Submission Portal
Find a Tender
Open the original notice
Click the button below to view the full notice on Find a Tender Service (FTS)
Check the procedure type
The "Procedure" section tells you if it's Open (one stage) or Restricted (SQ then ITT). This changes how you apply
Access the eSourcing portal
FTS notices link to the buyer's eSourcing platform — register there to access documents
Complete the Selection Questionnaire
Higher-value contracts often require an SQ first — this pre-qualifies you before the full bid stage
Submit electronically
Upload your completed response through the eSourcing platform before the closing date and time
FTS contracts are above UK procurement thresholds. Late submissions are strictly rejected — submit at least 24 hours before the deadline to avoid portal issues.
Useful Resources
Buyer Profile
NHS EnglandKey Dates
Published
4 June 2026
Submission deadline
8 July 2026
Notice type
tender
Source
find a tender
Related Contracts
Clinical Lead Associate Dentist (Contract for Services)
The University of East Anglia is hiring a Clinical Lead Associate Dentist to work in their on-campus dental practice. You'll be a senior clinical dentist providing patient care, leading a small team, and helping develop their dental training programme. This is a Contract for Services role (self-employed/freelance basis), not permanent employment.
Community Wheelchair Service in Bexley, Bromley and Greenwich
```json { "overview": "NHS South East London is looking for a provider to run a community wheelchair service for three London boroughs (Bexley, Bromley, Greenwich) serving children and adults. The service covers everything from assessing people's wheelchair needs through to delivering, fitting, repairing and maintaining wheelchairs and related equipment. The contract is worth £9–15 million over 5–7 years depending on the extension period.", "requirements": [ "Must be able to deliver services across all three boroughs (Bexley, Bromley, Greenwich) with equitable access and consistent service standards", "Must provide clinically safe services with robust safeguarding, risk management, incident reporting and clinical governance arrangements", "Must handle referral receipt and management, triage and prioritisation by clinical need", "Must conduct assessments, reviews and reassessments of wheelchair and mobility/postural support needs", "Must prescribe and provide appropriate wheelchairs and associated equipment", "Must fit, set up, hand over equipment and provide user/carer instruction", "Must deliver planned maintenance, urgent repairs and servicing of wheelchairs", "Must manage collection, refurbishment, reuse and replacement of equipment", "Must communicate effectively with service users, carers, referrers and partner agencies", "Must manage personal wheelchair budgets and choice-based approaches if required", "Must collect and report activity, access, quality, performance and outcome data", "Must serve diverse populations including children and young people, people with complex physical disabilities, progressive conditions, and those needing specialist seating/posture management", "Must provide accessible assessment arrangements and delivery locations, including community-based provision and support in other settings", "Must work closely with health, social care, education and community partners for coordinated care", "Must demonstrate approach to reducing waiting times for assessment, equipment provision and repairs", "Must support service sustainability, value for money, effective stock/asset management and continuous improvement", "No specific industry certifications or qualifications explicitly stated — check full procurement documents for clinical and operational accreditation requirements" ], "key_tasks": [ "Receive, triage and prioritise wheelchair service referrals for eligible residents across three boroughs", "Conduct clinical assessments and reassessments to determine wheelchair and postural support needs", "Prescribe and supply appropriate wheelchairs and associated equipment to service users", "Fit, set up and hand over wheelchairs to users and carers with instruction on use", "Deliver planned maintenance and routine servicing of all wheelchairs in use", "Respond to urgent repair requests and fix faulty equipment", "Collect used wheelchairs and manage refurbishment and reuse processes", "Manage replacement cycles for wheelchairs that cannot be repaired", "Maintain clear two-way communication with service users, carers and referring clinicians", "Manage personal wheelchair budgets or choice-based purchasing if the final model includes this", "Collect, analyse and report performance data on activity, waiting times, access, quality and outcomes", "Work with NHS, social care, education and community services to coordinate care for service users", "Reduce waiting times for assessments, equipment delivery and repairs compared to current service", "Ensure services are accessible and responsive to children, young people and adults with complex needs" ], "how_to_read": [ "This is a major NHS contract — the language is clinical and person-centred, but the core work is logistics, asset management and customer service. Don't be put off by health jargon; the service is fundamentally about managing wheelchair stock and keeping people mobile.", "The contract value is large (£9–15 million) but spread across five or seven years and three boroughs — work out what that means per borough, per year and per expected service user to understand the scale. The annual envelope is £1.8–2.2 million, so plan your staffing and operating costs accordingly.", "The 'optional extension period' means the ICB can renew for another two years, but it's their choice, not guaranteed. Plan for the five-year term as firm and the two-year extension as possible revenue.", "Watch for the phrase 'full procurement documents' — the tender notice gives you the headline requirements, but the detailed service specification, activity assumptions, performance targets and mobilisation timetable will be in documents you'll receive when you formally register. Request these early and read them thoroughly before deciding to bid.", "The ICB has done user and carer engagement already — they know what's currently wrong (slow assessments, poor communication, inconsistent repairs). Your bid should directly address these pain points with concrete actions. Look for the engagement feedback when it's published and build your solution around it.", "The contract starts 1 April 2027, which gives you planning time. This is not an emergency procurement — treat the timeline as your opportunity to design the service properly rather than rushing." ], "sme_tips": [ "Consider subcontracting or consortium partnerships: a small business may not have the geographic reach, clinical expertise or asset base to run this alone across three boroughs. Partner with a larger logistics or healthcare provider, or with local charities that have
CA18033 - Alcester Grammar School Tender for Cleaning Services
Alcester Grammar School in Warwickshire is looking for a cleaning contractor to provide regular cleaning services at their school site on Birmingham Road. This is a straightforward facilities management contract to keep the school buildings and grounds clean and maintained.
Community Tier 2 Gynaecology Service for NHS Lancashire and South Cumbria Integrated Care Board
The NHS Lancashire and South Cumbria Integrated Care Board is looking for a single healthcare provider to deliver routine gynaecology services (non-urgent) across four local areas in Lancashire and South Cumbria. The contract is worth approximately £10 million over 3 years, with an optional 2-year extension, and will serve patients with benign gynaecology conditions who don't need urgent or cancer-suspected care.